Treatment of angiosarcoma with pazopanib and paclitaxel: Results of the phase II trial of the German Interdisciplinary Sarcoma Group (GISG-06 EVA) study.

11570Background: Angiosarcomas (AS) account for 2-3% of all soft tissue sarcomas. About 60% develop at the skin, and radiation-induced AS following breast cancer therapy represent a characteristic ...